RU58841 Guide
Topical Anti-Androgen for Hair Loss 2026
Complete guide to RU58841 — the research topical anti-androgen that blocks DHT at scalp androgen receptors.
Topical Anti-Androgen: DHT Blocker at the Scalp (Research Use 2026)
RU58841 is a research topical anti-androgen applied directly to the scalp that locally blocks dihydrotestosterone (DHT) at androgen receptors in hair follicles — halting androgenetic alopecia progression without the systemic side effects of finasteride or dutasteride.
What Is RU58841?
RU58841 (PSK-3841) is a non-steroidal anti-androgen originally developed for topical application in the 1980s-90s. It functions as a high-affinity androgen receptor (AR) antagonist — binding scalp AR with ~3-4x the affinity of DHT without activating the receptor. This competitive inhibition prevents DHT from signaling hair follicle miniaturization. Unlike systemic anti-androgens (finasteride, dutasteride), which reduce serum DHT levels and carry sexual side effects, RU58841 acts locally at the scalp with minimal systemic exposure. It is a research chemical — not FDA approved — but is widely used in the hair loss community as a hair-preserving adjunct.
Most widely used topical concentration in research protocols
Minimal systemic DHT suppression — primarily scalp-level action
Maintenance of hair density requires consistent long-term use
Key Biohacking Mechanics
Binds scalp AR with higher affinity than DHT
Competitive blockade — no receptor activation (no androgenic effect)
Prevents DHT-mediated follicle miniaturization signaling
Preserves existing terminal hair follicle function
Undergoes rapid photolytic/metabolic breakdown
Minimal systemic absorption compared to finasteride
Does not suppress blood DHT levels significantly
Preserves male hormonal profile in most users
Macaque hair regrowth studies show strong efficacy
Shown to arrest progression rates comparable to finasteride in some models
No direct large-scale human RCT data (research compound)
Anecdotally: widely reported hair preservation in NW2-NW4 MPB
Minoxidil: complementary (minoxidil = growth stimulation; RU58841 = DHT blockade)
Microneedling: improves topical penetration to follicle level
Ketoconazole shampoo: reduces scalp inflammation
Finasteride stack used by some — systemic + local coverage
Dosing Protocol
Beginner Protocol
Start at 2.5% for 4 weeks. Apply 1mL to dry scalp nightly. Massage for 30 seconds into thinning zones. Allow to dry before pillow contact
Standard Protocol
5% solution — 1mL per application. Once daily, preferably PM. Stack with minoxidil AM application. Track progression with monthly photos in Shotlee
Monitoring Approach
Photograph hairline and crown monthly. Track any systemic side effects (rare but monitor). Check serum DHT if concerned (typically unchanged). Cycle logs in Shotlee for long-term data
Side Effects & Safety
Advantages Over Systemic AADs
No sexual side effects (unlike finasteride/dutasteride). No systemic DHT suppression. No impact on PSA, fertility or libido typically. Reversible — discontinue and androgen receptors normalize
Reported Concerns
Scalp irritation at high concentrations. Contact dermatitis in sensitive individuals. Some users report mild systemic sides at very high doses. Degradation if improperly stored (heat-sensitive compoun
Vital Protocol FAQs
Does RU58841 stop hair loss?
Research data and community reports suggest RU58841 arrests androgenetic alopecia progression in most users who apply it consistently. Animal studies show strong AR antagonism at the follicle level. A
Is RU58841 safer than finasteride?
RU58841\'s primary advantage over finasteride is avoiding systemic DHT suppression — which is responsible for finasteride\'s sexual side effects (impotence, reduced libido, gynecomastia in some men).
How do I track my RU58841 protocol?
Shotlee supports tracking research compound protocols. Log daily applications with dose, time, and scalp area. Use the notes field to document monthly hair progression assessments. Set a monthly remin
Guide FAQs
Complete guide to RU58841 — the research topical anti-androgen that blocks DHT at scalp androgen receptors.
Yes. Shotlee supports tracking Ru58841 doses, side effects, and health metrics. It is free to use.
References
Track Your Ru58841 Protocol in Shotlee
Free dose logging, side effect tracking, and health metric monitoring for your complete protocol.
🚀 Use Shotlee for Free